Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 4649-4654, September 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferradini, L.
Right arrow Articles by Hercend, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferradini, L.
Right arrow Articles by Hercend, T.

Analysis of T-Cell Receptor {alpha}/ß Variability in Lymphocytes Infiltrating a Melanoma Metastasis1

Laurent Ferradini, Sergio Roman-Roman, José Azocar, Marie-Françoise Avril, Sophie Viel, Frédéric Triebel and Thierry Hercend2

Laboratoire d'Hémato-Immunologie, INSERM U333, Institut Gustave Roussy, 94805 Villejuif Cedex, France

Multiple experimental and clinical studies have suggested that the immune system may, to some extent, control the development of melanomas. The presence of tumor-infiltrating lymphocytes could reflect an in situ immune reaction directed to the malignant cells. The characterization of T-cell receptor (TCR) expressed by tumor-infiltrating lymphocytes is one way to precisely analyze these local T-cell responses. In this study, we have assessed the TCR {alpha}/ß variability in tumor-infiltrating lymphocytes from a subcutaneous metastasis of a melanoma patient. Using the anchored-polymerase chain reaction 268 TCR {alpha} and 266 TCR ß chain transcripts have been cloned and sequenced. Their analysis shows that the T-cell infiltrate is extremely diverse, with no preferential TCR gene segment usage.

1 Supported in part by ADRC Grants 2110 and 6338.

2 To whom requests for reprints should be addressed, at Laboratoire d'Hémato-Immunologie, INSERM U333, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France.

Received 1/15/92. Accepted 6/23/92.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Ito, S. Shichijo, N. Tsuda, M. Ochi, N. Harashima, N. Saito, and K. Itoh
Molecular Basis of T Cell-mediated Recognition of Pancreatic Cancer Cells
Cancer Res., March 1, 2001; 61(5): 2038 - 2046.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
D. Valmori, V. Dutoit, D. Lienard, F. Lejeune, D. Speiser, D. Rimoldi, V. Cerundolo, P.-Y. Dietrich, J.-C. Cerottini, and P. Romero
Tetramer-Guided Analysis of TCR {beta}-Chain Usage Reveals a Large Repertoire of Melan-A-Specific CD8+ T Cells in Melanoma Patients
J. Immunol., July 1, 2000; 165(1): 533 - 538.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Hishii, D. Andrews, L. A. Boyle, J. T. Wong, F. Pandolfi, P. J. van den Elsen, and J. T. Kurnick
In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites
PNAS, February 18, 1997; 94(4): 1378 - 1383.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.